LEADER 03482nam  2200973z- 450 
001 9910557552303321
005 20210501
035   $a(CKB)5400000000044083
035   $a(oapen)https://directory.doabooks.org/handle/20.500.12854/68386
035   $a(oapen)doab68386
035   $a(EXLCZ)995400000000044083
100   $a20202105d2021      |y         0
101 0 $aeng
135   $aurmn|---annan
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aCocrystal Applications in Drug Delivery
210   $aBasel, Switzerland$cMDPI - Multidisciplinary Digital Publishing Institute$d2021
215   $a1 online resource (172 p.)
311 08$a3-03943-983-9 
311 08$a3-03943-984-7 
330   $aIn 2015, the first pharmaceutical cocrystal was approved by the FDA. Since then, the number of cocrystals on the market and in the development pipeline has been slowly but steadily growing. It is now well established that cocrystals are a versatile new approach to oral drug formulation. This Reprint Book is a collection of articles that show the utility of pharmaceutical cocrystals and various aspects of cocrystal research: ? Cocrystals as a strategy to modify the physicochemical properties of a drug such as dissolution behaviour, tabletability, and melting point; ? Development of new coformers; ? Screening studies for multiple cocrystal forms; ? Cocrystals in nano-sized drug delivery.
606   $aResearch & information: general$2bicssc
610   $abarbituric acid
610   $acocrystal
610   $acocrystals
610   $acompaction
610   $acrystal engineering
610   $acrystal structure
610   $acrystallization inhibitors
610   $adesign of experiments
610   $adiclofenac sodium
610   $adissolution
610   $adissolution behavior
610   $adissolution rate
610   $adrug-polymer interactions
610   $aformulation
610   $aHIV/AIDS
610   $aimidazole N-oxides
610   $ainterparticulate bonding area
610   $ainterparticulate bonding strength
610   $aitraconazole
610   $aL-proline
610   $alamivudine
610   $amechanochemistry
610   $amonohydrate
610   $amulticomponent crystal
610   $amulticomponent crystals
610   $an/a
610   $anano co-crystals
610   $ananoindentation
610   $anefiracetam
610   $anitazoxanide
610   $aparticle size
610   $apharmaceutical cocrystals
610   $apolydispersity index
610   $aQuality by Design
610   $asalt cocrystal
610   $aslip plane
610   $asolid state
610   $asolid state NMR
610   $asolid-state
610   $asolubility
610   $asonochemistry
610   $astability
610   $asupersaturated formulations
610   $asurface topology
610   $atabletability
610   $aterephthalic acid
610   $atetrahydrate
610   $athermal analysis
610   $athiobarbituric acid
610   $awettability
610   $aX-ray Diffraction
610   $azeta potential
610   $azidovudine
615  7$aResearch & information: general
700   $aErxleben$b Andrea$4edt$01290197
702   $aErxleben$b Andrea$4oth
906   $aBOOK
912   $a9910557552303321
996   $aCocrystal Applications in Drug Delivery$93021414
997   $aUNINA